Skip to Content
Merck

HPLC Analysis of Sibutramine Enantiomers on Astec® CHIROBIOTIC® V2

HPLC Analysis of Sibutramine Enantiomers on Astec® CHIROBIOTIC® V2 application for HPLC

Materials

analytical column

Product No.
Description
Pricing

15024AST

Astec® CHIROBIOTIC® V2 Chiral HPLC Column

5 μm particle size, L × I.D. 25 cm × 4.6 mm

CONDITIONS

column

CHIROBIOTIC V2, 25 cm x 4.6 mm I.D., 5 μm particles (15024AST)

mobile phase

15 mM ammonium formate in methanol

flow rate

1 mL/min

column temp.

25 °C

detector

UV, 230 nm

injection

10 μL

sample

1 mg/mL in methanol

Description

Analysis Note

Sibutramine, one of a few drugs approved for long-term treatment of obesity, is a chiral compound. The (R) enantiomer has the desired effect of reducing body weight and food intake, but the (S) enantiomer has the opposite effect: A perfect example of why chiral HPLC is important to pharmaceutical and clinical analysts. Astec® CHIROBIOTIC® V2 successfully separates sibutramine enantiomers, using a simple, MS-friendly mobile phase.

Legal Information

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC

Chromatogram Search

Related Product Categories

HPLC ColumnsGC Columns & AccessoriesTLC Plates & AdsorbentsSolid Phase Microextraction (SPME)Solid Phase Extraction & QuEChERS

Related Applications

Small Molecule HPLCLarge Molecule HPLCGas Chromatography (GC)TLCSolid Phase Microextraction (SPME)Solid Phase Extraction (SPE)QuEChERS